Cite
MLA Citation
Charlotte I Stroes et al.. “A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).” Therapeutic advances in medical oncology, vol. 14, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169888349.0x000111